According to a study published in the New England Journal of Medicine, researchers at The Institute of Cancer Research (ICR) have demonstrated how to prevent new cancers that can occur when malignant melanoma patients are treated with drugs known as BRAF inhibitors. In the past, doctors have observed that between 15 and 30% of patients who were treated with BRAF inhibitors, including the FDA ...